American Society of Interventional Pain Physicians | February 6, 2019
One Day Ultrasound Course February 21, 2019
Orlando, FL
FEW SPOTS REMAIN!
Limited Hotel Rooms Available
3 Choices in February!
Review Courses and Cadaver Labs
Feb 22-24 2019, Orlando, FL
REGISTRATION  |   HOTEL  |   EXHIBITOR |
REGISTRATION  |   HOTEL  |   EXHIBITOR  | BROCHURE
Abstract Submission Deadline February 18

Abstract submissions are now being accepted for the 2019 ASIPP Annual Meeting Abstract and Poster Contest. The top 10 abstracts selected by our panel will be presented at the annual meeting. The top 25 abstracts will be presented as electronic posters in view for all our attendees.

Click HERE to submit. Deadline is Feb. 18

JULY ABIPP EXAMS
AND COMPETENCY EXAMS
July 13 - July 14 | Memphis, TN
 
The American Board of Interventional Pain Physicians ( ABIPP ) has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management
profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become ABIPP certified.
 
ABIPP now offers the only competency certification program for regenerative medicine.
 
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org or call 270-554-9412 x4217 or by email at summer@asipp.org.

July 13
ABIPP Part I
 
July 13-14
ABIPP Part II
 
July 14
ABIPP Competency Exam

July 13
Combined CSM/CCPM Exam for ABIPP Path
July 13
Competency Exam in Controlled Substance Managemen

July 13
Competency Exam in Coding, Compliance, and
Practice Management

July 13-14
Regenerative Medicine Competency Exam
 
July 13-14
Endoscopic Lumbar Decompression Competency Exam

939 Ridge Lake Blvd. | Memphis, TN 38120
 
The cut-off date for our room block with discounted rates is on June 10, 2019 or until sold out, whichever occurs first.
An Evidence-Based Road Map to Navigating the Opioid Epidemic


Opioid use disorder  (OUD), which is "often secondary to non-medical use of prescription opioids" is a major public health issue in the United States to the extent that it has been called an epidemic. 1  In October 2018, President Trump announced that his administration was declaring the opioid crisis a national public health emergency under federal law and directing all executive agencies to "use every appropriate emergency authority to fight the opioid crisis." 2  Opioid-related overdoses have risen "exponentially," increasing at a rate of 9% annually. 3  According to US Department of Health and Human Services, in 2016 and 2017, 11.4 million people misused prescription opioids, 2.1 million people had an OUD, and 42,249 people died of opioid-related overdoses. 4


Regenerative Medicine and Antithrombotic Guidelines Now Available


Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines


Responsible, Safe, and Effective Use of Antithrombotics and Anticoagulants in Patients Undergoing Interventional Techniques: American Society of Interventional Pain Physicians (ASIPP) Guidelines

2018 Pain Management Salary Survey Results
Does your pay slay or is it just OK?

Health Media designed and conducted the online survey obtaining over 20,000 responses. 7,753 of the responses provided salary information and were used in the analysis


Targeting Opioid Scripts May Have Little Effect on Epidemic

Dose limits, prescribing guidelines, prescription drug monitoring programs, and similar interventions will have a "modest effect, at best" on the number of opioid overdose deaths in the future, a mathematical model projected.
Lowering the incidence of prescription opioid misuse from 2015 levels would decrease overdose deaths only 3% to 5% by 2025, according to Jagpreet Chhatwal, PhD, of Massachusetts General Hospital in Boston, and colleagues, writing in  JAMA Network Open .



Interventional Pain Management Reports is an Open Access online journal, a peer-reviews journal dedicated to the publication of case reports, brief commentaries and reviews and letters to the editor. It is a peer-reviewed journal written by and directed to an audience of interventional pain physicians, clinicians and basic scientists with an interest in interventional pain management and pain medicine. 

Interventional Pain Management Reports is an official publication of the American Society of Interventional Pain Physicians (ASIPP) and is a sister publication of Pain Physician . Interventional Pain Management Reports Interventional Pain Management Reports is an open access journal, available online with free full manuscripts.  

The benefits of publishing in an open access journal that has a corresponding
print edition journal are:  
  • Your article will have the potential to obtain more citations.
  • Your article will be peer-reviewed and published faster than other journals.
  • Your article can be read by a potentially much larger audience compared with traditional subscription-only journals.  
  • Open Access journals are FREE to view, download and to print.

So submit today your:
  • Case Reports
  • Technical Reports
  • Editorials
  • Short Perspectives

Pain Physician
January/February 2019 Issue Features

Sjors H. Wagemakers, MD, Joanne M. van der Velden, MD, PhD, A. Sophie Gerlich, MD, Alinde W. Hindriks-Keegstra, MD, Jacqueline F.M. van Dijk, PhD, and Joost J.C. Verhoeff, MD, PhD.
Cui Zhiyong, MD, Tian Yun, MD, Feng Hui, MD, Yang Zhongwei, MD, and Liu Zhaorui, MD.

Zung Vu Tran, PhD, Anna Ivashchenko, MPH, and Logan Brooks, BA.
Peng-Fei Wu, BD, Ya-Wei Li, MD, Bing Wang, MD, Bin Jiang, BD, Zhi-Ming Tu, BD, and Guo-Hua Lv, MD.

Parisa Nejati, MD, Afsaneh Safarcherati, MD, and Farshid Karimi, MD.


CMS Proposes Lower Cost-Sharing for Naloxone

WASHINGTON -- Medicare beneficiaries at risk for opioid overdose may see reduced cost-sharing for naloxone under a proposed policy announced by the Centers for Medicare & Medicaid Services (CMS), in response to calls to make the overdose-reversal agent more widely available.
"The agency is continuing to work to combat the nation's opioid crisis," said Demetrios Kouzoukas, director of the Center for Medicare at CMS, on a phone call with reporters Wednesday. "Many new policies are being implemented in 2019, including Part D drug management programs for high-risk opioid users and improved safety alerts such as a 7-day supply limit for opioid-naive patients. CMS will evaluate the success and impact of these policies in 2019 and is proposing to continue them into 2020."



Orchard Park pain doctor pleads guilty to using patient names fraudulently to obtain controlled substances
BUFFALO, N.Y. – DEA New York Division Special Agent in Charge Ray Donovan and U.S. Attorney James P. Kennedy, Jr., announced today that Dr. Paul Biddle, 54, of Amherst, N.Y., pleaded guilty before U.S. District Judge Elizabeth A. Wolford to identity theft and possession of unlawful hydromorphone HCL. The charges carry a maximum penalty of five years in prison.
Assistant U.S. Attorney Michael J. Adler, who is handling the case, stated that Biddle was an anesthesiologist and pain management doctor who also operated a medical marijuana practice. Between Feb. 9, 2015, and Oct. 16, 2017, the defendant was prescribing controlled substances for two deceased patients. Biddle knew the patients were deceased and used their names and dates of birth knowingly and without lawful authority to obtain controlled substances for himself.


DEA
vanti Hospitals Llc, and Its Owners Agree to Pay $8.1 Million to Settle Allegations of Making Illegal Payments in Exchange for Referrals
The Department of Justice announced that on Dec. 28, 2018 Los Angeles-based Avanti Hospitals LLC (Avanti) and six of its owners will pay the federal government $8.1 million to settle claims that they violated the False Claims Act by submitting, or causing Avanti’s subsidiary, Memorial Hospital of Gardena (Gardena Hospital), to submit false claims to the Medicare and Medicaid programs for medical services referred by a physician who received kickbacks and other improper payments from Gardena and other Avanti affiliates. 
“Financial arrangements that improperly compensate physicians for referrals encourage physicians to make decisions based on financial gain rather than patient needs,” said Assistant Attorney General Jody Hunt for the Department of Justice’s Civil Division. “The Department of Justice is committed to preventing illegal financial relationships that undermine the integrity of our public health programs.”
The government alleged that the payments from Avanti, Gardena Hospital and at least two other Avanti affiliates to a high-referring physician violated the Anti-Kickback Statute and the Physician Self-Referral Law, commonly known as the Stark Law. The Anti-Kickback Statute prohibits offering, paying, soliciting, or receiving remuneration to induce referrals of items or services covered by Medicare, Medicaid, and other federally funded programs. The Stark Law prohibits a hospital from billing Medicare for certain services referred by physicians with whom the hospital has an improper compensation arrangement. Both the Anti-Kickback Statute and the Stark Law are intended to ensure that a physician’s medical judgment is not distorted by improper financial incentives and is instead based only on the best interests of the patient.


DOJ
State Society News 

July 12-14, 2019
GSIPP 2019 - 15th Annual Meeting & Pain Summit
The Cloister Hotel at Sea Island
Sea Island, GA
For more information, contact Karrie Kirwan at karrie@theassociationcompany.com or Tara Morrison at tara@theassociationcompany.com or 770-613-0932.

July 26-28, 2019
PAIN 2019
West Virginia Society of Pain Physicians
Loews Miami Beach, FL


Send in your state society meeting news to Holly Long, hlong@asipp.org
ASIPP | Pain Physician Journal | Phone | Fax | Email